Recently, we demonstrated that islet transplantation from non-heart-beating donors (NHBDs) using the Kyoto islet isolation method (KIIM) successfully reversed patients' diabetes state. In this study, we evaluated the effects of donor-and isolation-related variables on islet isolation results from NHBDs by KIIM. Twentyone islet preparations from the pancreata of NHBDs were isolated by KIIM. Islet preparations that met transplantation criteria and achieved improved patient diabetes control after transplantation were defined as successful isolations. Potential risk factors deemed to affect islet isolation results, such as age, gender, body mass index, hospital stay, donors' blood biochemical tests, a modified pancreata procurement method, and isolation and purification procedure-related variables, were analyzed. Seventeen out of 21 islet isolations (81%) were successful isolations. Postpurification islet yield was 447,639 ± 39,902 islet equivalents (IE) in the successful isolation group and 108,007 ± 31,532 IE in the failure group. Donor age was significantly younger in the success group (41.9 ± 4.0 years old in the success group vs. 57.5 ± 2.2 years old in the failure group, p = 0.003). Chronic pancreatitis significantly decreased islet yields (p = 0.006). Phase I time was significantly shorter (p = 0.010) and undigested tissue volume was significantly smaller (p = 0.020) in the success group. Purity was in positive correlation to postpurification islet yield, while donor age was in reverse correlation to postpurification islet yield. KIIM enables us to perform islet transplantation from NHBDs; however, the decision to use pancreata from older donors or those with chronic pancreatitis requires careful consideration.
INTRODUCTION
is categorized as tissue transplantation and heart-beating brain-dead donors are not allowed. This leaves the potential donor pool to come from only non-heart-beating After the Edmonton group showed that transplantation of human islets of Langerhans could be a novel donors (NHBDs) (10,11,14) and living donors (12, 15) . Previously, we initiated the Kyoto Islet Isolation Method treatment for patients with type 1 diabetes mellitus (22) , the problem of donor shortage became prominent in islet (KIIM), which was modified for NHBDs (11, 19) and manipulated 21 islet preparations from the pancreata of transplantation. A non-heart-beating donor (NHBD) pool might be a beneficial supplement to alleviate donor NHBDs. It was encouraging that 17 out of 21 (81%) islet preparations from NHBDs met the transplantation shortage in the islet transplantation field (5) ; however, few islet teams prefer manipulating such a pancreas be-criteria, and were transplanted into eight patients. All patients achieved improved blood glucose levels after cause of its notorious difficulty in islet isolation and purification (9). In Japan, pancreatic islet transplantation transplantation with no hypoglycemia episodes, reduced 650 LIU ET AL.
insulin requirement, and three instances of insulin inde-Six density test tubes were prepared with 5 ml of purification solution of different densities (1.085, 1.090, 1.095, pendence (11).
We were curious to identify the risk factors from 1.100, 1.105, and 1.110 g/cm 3 ) and covered by 1 ml cap solution (dithizone, Sigma Chemical Co., St. Louis, NHBDs using the KIIM in order to gain a higher success rate. In this study, we review our experience of islet MO) (0.5 mg/ml, in Hanks' balanced salt solution). The different densities were achieved by adjusting the ratio isolation and purification with KIIM from NHBDs, and analyze possible donor-and procedure-related variables of iodixanol (OptiPrep, Axis-Shield PoC AS, Norway) to M-Kyoto solution. Samples were taken from the iso-affecting islet yield. lation aggregates and added to the discontinuous density MATERIALS AND METHODS test tubes. The tubes were spun at 1000 rpm for 5 min Donor Background and the densities of aggregates were determined by whether they pelleted or floated in the different density Twenty-one pancreata from NHBDs were procured solutions. Islets were purified with a continuous density through the Japan Organ Transplantation Network begradient of iodixanol/M-Kyoto solution (Ulinastatin tween April 7, 2004 and January 21, 2006. The study 50,000 U/L in ET-Kyoto solution) in an apheresis syswas approved by the Ethics Committee of the Kyoto tem (COBE 2991 cell processor, Gambro Laboratories, University Graduate School and Faculty of Medicine.
Denver, CO) (11). The heavy density solution was cho-The average donor age was 44.9 ± 3.5 years old, body sen according to the test tube density adjustment method weight was 59.4 ± 2.7 kg, body mass index (BMI, described above and the gradient was achieved by varyweight in kg/height in m 2 ) was 21.9 ± 0.7 kg/m 2 , and ing the ratio of iodixanol to M-Kyoto solution. pancreas weight was 87.9 ± 5.8 g. Average warm ischemic time (WIT, time from donor death to chilling solu-Islet Evaluation tion perfusion) was 7.9 ± 2.2 min and cold ischemic time (CIT, time from chilling solution perfusion to initi-Islet evaluation was independently judged by two ination of isolation) was 253.1 ± 16.9 min.
vestigators. Islet yield was determined with dithizone staining (2 mg/ml, Sigma Chemical Co.) under optical Pancreata Procurement, Islet Isolation, graticule and converted into a standard number of islet and Purification equivalents (IE, diameter standardizing to 150 µm) All 21 islet preparations were manipulated according (13, 21) . Purity was assessed by comparing the relative to GMP (Good Manufacturing Practice) at the Center quantity of dithizone-stained tissue to unstained exofor Cell and Molecular Therapy of Kyoto University crine tissue. Mantled islets were defined as more than Hospital. Islet isolation was performed according to 50% of the islet surface being covered by exocrine tissue KIIM, which is based on the Ricordi method with some (13). Islet viability was evaluated using acridine orange modifications (11). The key procedures are described as (10 µmol/L) and propidium iodide (15 µmol/L) (AO/PI) follows. We procure pancreata in conjunction with kidstaining to visualize living and dead cells simultaneously neys taken by the kidney procurement team. This is (13,21). Islet function was evaluated by the insulin sedone by inserting double-balloon catheters into the iliac cretory response of the purified islets during a glucose vessels before cardiac arrest and after confirmation of stimulation test (13,21). brain death and informed consent. We start regional organ chilling after cardiac arrest using an in situ regional Grouping organ cooling (ISRC) system (17) . The pancreas is protected during kidney procurement and is removed after Islet preparations that met transplantation criteria (11,22) and improved patient diabetes control after the kidney. We remove the duodenum and spleen from the pancreas at the procurement site. A cannula is imme-transplantation were included in the success group, and those that did not, in the failure group. Features of im-diately inserted into the procured pancreas through the main pancreatic duct from the direction of the pancreatic proved patients' diabetes include stable blood glucose control without hypoglycemic unawareness, improved head and M-Kyoto solution is administered intraductally (11,18). M-Kyoto solution is 100,000 U/L of Ulinastatin hemoglobin A 1C (HbA 1C ) levels with positive C-peptide, and reduced exogenous insulin requirement. (Mochida Pharmaceutical Co Ltd, Tokyo, Japan) in ET-Kyoto solution (Kyoto Biomedical Science, Kyoto, Ja-Donor-and isolation-related factors were analyzed, including: age, gender, BMI, pancreatic status (healthy pan). For pancreas preservation during transportation, we use an oxygenated perfluorocarbon/M-Kyoto solu-vs. chronic pancreatitis), donors' hospital stays, donors' blood biochemistry tests [peak transaminase levels, peak tion-based two-layer method (11,18) instead of UW solution. We check the density of the isolation aggregates creatinine levels, peak amylase, peak blood urea nitrogen (BUN) levels, and peak blood glucose levels], car-with a test tube density adjustment method as follows. diac arrest or norepinephrine administration, ISRC sys-of mantled islets was 30.9 ± 5.2%. The average insulin stimulation index was 4.2 ± 1.8. tem, perfusion time and volume, WIT, CIT, phase I time (time from placement in the Ricordi chamber to the start Donor Characteristics of collection), phase II time (time of collection), undi-Donor characteristics were analyzed based on success gested tissue volume, and prepurification islet yield (IE, and failure groups ( Table 1 ). The average postpurificaand IE/g).
tion islet yield was 447,639 ± 39,902 IE in the success group and 108,007 ± 31,532 IE in the failure group.
Statistical Analysis
There were no significant differences between the two Differences between means were compared with the groups in gender, BMI, hospital stay, peak creatinine independent t-test. Differences between ratios were analevel, peak BUN level, peak blood glucose level, peak lyzed with Fisher's exact test. Logistic regression analyamylase level, peak transaminase level, or norepinephsis was performed to determine factors affecting islet rine administration. yield. All statistical analyses were performed using the Significant differences were found in donors' ages Statistical Package for the Social Sciences (SPSS 10.0, and pancreata status between the two groups. The donor SPSS, Chicago, IL). Data were expressed as the average age in the success group was 41.9 ± 4.0 years old and ± SEM and p < 0.05 was considered significant.
in the failure group 57.5 ± 2.2 years old (p = 0.003). All of the 21 pancreata underwent histological examination RESULTS with hematoxylin and eosin staining (H&E stain). Pan-Overall Isolation Results creata with diffuse fibrosis were defined as chronic pan-In all cases after islet transplantation, HbA 1C levels creatitis (n = 7) and those without evidence of inflamwere improved ( Fig. 1 ) and there was no hypoglycemic mation were defined as healthy pancreata (n = 14). In unawareness. Therefore, all preparations that met transthe success group, 3 out of 17 pancreata had chronic plantation criteria were included in the success group. pancreatitis (CP); while in the failure group, all four Thus, 17 out of 21 islet preparations achieved success cases had CP (p = 0.006) ( Table 1) . (a success rate of 81%). Average islet yield (from both Isolation Characteristics the success and failure groups) before purification was 508,622 ± 59,473 IE (6,010 ± 665 IE/g), and after puri-Isolation characteristics were also analyzed based on success and failure groups ( Table 2 ). The success group fication was 382,945 ± 44,146 IE (4,589 ± 504 IE/g). Purity after purification was 46.8 ± 3.3%. Viability as-had a significantly shorter phase I time (p = 0.010) and significantly smaller undigested tissue volume (p = 0.020). sessed by AO/PI after purification was 96.2 ± 0.7%, and all samples were above 85%. The average percentage Although there was no significant difference, the suc- cess group had about a twofold higher percentage of gests that pancreatitis inhibits pancreas digestion and leads to low islet yield and low purity. mantled islets. This was due to our modified purification method using the density adjustment method before pu-Relationship Between Postpurification Islet Yields rification, which enhanced the recovery of mantled islets and Other Factors in all cases. Obviously, the prepurification islet yield was the most striking factor for success.
Purity was positively correlated with postpurification islet yield (R = 0.619, p = 0.003) ( Fig. 2A) . Donor age Effect of Pancreata Status was inversely correlated with the postpurification yield (R = −0.616, p = 0.003) (Fig. 2B) . The insulin stimula-Because CP adversely affected the isolation success rate (Table 1) , we further analyzed the effect of pan-tion index and islet viability showed no correlation with postpurification islet yield (IE/g) (R = 0.014, p = 0.953 creata status on islet isolation ( Table 3 ).
The donor age was significantly older in the CP and R = 0.318, p = 0.161, respectively) ( Fig. 2C, D) . group (p = 0.002), suggesting that aging is correlated DISCUSSION with CP onset. The phase I time was significantly longer (p = 0.001) and the undigested tissue volume was signif-Previous studies reported several factors that had significant impact on islet isolation using brain-dead heart-icantly larger (p = 0.016) in the CP group, which sug- beating donors (2, 4, 8, 16, 25) ; however, this is the first optimal density gradient range, we successfully collected mantled islets. In fact, in our success group, more time that factors relating to the use of NHBDs for actual clinical islet transplantation have been reported. Al-than 30% of all mantled islets might have been lost if we had not utilized this technique. Although exocrine though our data set is small, the results are interesting and should be helpful for assessing pancreata from tissue may hinder the ability of nutrition to diffuse to the islets (6), the detachment of islets from exocrine tissue NHBDs before islet processing.
In terms of donor factors, although overweight older triggered an apoptotic signal and resulted in islet death (24) . Investigators have confirmed the advantages of is-donors have been considered more suitable for islet isolation than younger donors (4,8), our study highlighted lets from young donors, both in vitro in terms of insulin secretory function (7) and in vivo after transplanting to the benefit of using pancreata from young donors for islet preparations. In our study, the donor age in the suc-diabetic mice (1) . We believe that if we can only recover mantled islets from young donors, the islet preparations cess group was quite young. Additionally, donor age showed an inverse correlation with postpurification islet should be of high quality both in function and in islet number. yield. The main obstacle to gaining high postpurification islet yields from young donors lies in the higher percent-
The pancreatic status of donors, especially those with CP, could severely affect the isolation results. To ana-age of mantled islets, which are embedded in acinar tissue (20). Due to anatomical and physiological differ-lyze this, we further investigated the effect of the pancreata status on islet isolation and transplantation (Table ences of the pancreata from young donors, it is difficult for islets to be separated from acinar tissue without over-3). In our study population, CP is defined as diffuse fibrosis after H&E histological staining. Phase I time (di-digestion and islet fragmentation (8). To avoid overdigestion, mantled islets were accepted and collected after gestion time) was significantly longer and undigested tissue volume was significantly larger in the CP group. isolation. However, because they were surrounded by exocrine tissue, the density of mantled islets differed These were due to the difficulty in digesting a pancreas with CP and led to failed islet isolation. In addition, pu-from that of isolated islets and resulted in difficulty in extraction from the exocrine tissues during purification.
rity was significantly lower in the CP group, suggesting that, even by sacrificing purity, it was still hard to obtain In the case of mantled islets from young donors, the standard islet isolation method with fixed purification a high islet yield from pancreata with CP. Because donor age was significantly older in the CP group (Table  density can achieve a large quantity of IE before purification but cannot recover mantled islets after purifica-3) and older pancreata are more prone to CP, this is another reason to seek younger donors. Based on our tion.
Socci et al. (23) discovered that the ducts in young data, older NHBDs with chronic pancreatitis are an apparent risk factor for islet isolation. A multicenter, large-pancreata collapse, which hampers the enzyme solution from thoroughly infusing and uniformly distributing scale, randomized trial will be necessary to verify this. Importantly, all cases within the healthy pancreata group throughout the parenchyma, leading to mantled islets. In KIIM, we immediately insert a cannula into the main (14/14) resulted in successful islet isolation and transplantation. This was especially important for confirming pancreatic duct on the duodenal terminus after procurement and ductally administer M-Kyoto solution (11, 18) .
that KIIM was a reliable islet isolation method with normal pancreata. It allowed us to perform living donor is-Two key features of this approach are: 1) Ulinastatin, a trypsin inhibitor in M-Kyoto solution, helps protect the let transplantation successfully with KIIM (12). A reliable islet isolation method is of crucial importance when main duct wall from trypsin injury, and 2) we fill the pancreatic duct system with M-Kyoto solution to main-performing living donor islet transplantation. Other donor-related factors such as BMI, pancreas tain the three-dimensional duct system and prevent its collapse. Also, M-Kyoto solution shows a lower Liber-weight, length of hospital stay, peak transaminase level, peak creatinine level, peak amylase level, peak BUN ase inhibition than UW solution (18) , which contributes to sufficient digestion of the pancreas and decreases the level, norepinephrine administration, or cardiac arrest showed no significant effects on islet preparation results. amount of mantled islets. Efforts were taken to improve the infusion efficiency of the enzyme and thus increase This might be due to our modified procedures in KIIM, which could overcome these obstacles. Another possible the level of whole pancreas digestion (to lower the number of mantled islets). Even with this effort, we still col-reason is the limited size of our study population. For instance, BMI is a decisive indicator of a subject's nutri-lected some mantled islets after isolation. In order to recover this fraction of islets, we individualized the den-tional status and lean donors (with BMI <24 kg/m 2 ) had significantly lower islet yields (3, 8) . However, in our sity of the high-density purification solution for each islet preparation before purification based on the results study population, most of the donors were of low BMI (range 14.8-27.2 kg/m 2 ). It is hard to tell based on our of the test tube density adjustment method. By using an
